GB1219606A
(en)
|
1968-07-15 |
1971-01-20 |
Rech S Et D Applic Scient Soge |
Quinuclidinol derivatives and preparation thereof
|
GB1524747A
(en)
|
1976-05-11 |
1978-09-13 |
Ici Ltd |
Polypeptide
|
EP0100172B1
(en)
|
1982-07-23 |
1987-08-12 |
Imperial Chemical Industries Plc |
Amide derivatives
|
GB8327256D0
(en)
|
1983-10-12 |
1983-11-16 |
Ici Plc |
Steroid derivatives
|
US5093330A
(en)
|
1987-06-15 |
1992-03-03 |
Ciba-Geigy Corporation |
Staurosporine derivatives substituted at methylamino nitrogen
|
GB8916480D0
(en)
|
1989-07-19 |
1989-09-06 |
Glaxo Group Ltd |
Chemical process
|
US5010099A
(en)
|
1989-08-11 |
1991-04-23 |
Harbor Branch Oceanographic Institution, Inc. |
Discodermolide compounds, compositions containing same and method of preparation and use
|
GB8923590D0
(en)
|
1989-10-19 |
1989-12-06 |
Pfizer Ltd |
Antimuscarinic bronchodilators
|
US5395855A
(en)
|
1990-05-07 |
1995-03-07 |
Ciba-Geigy Corporation |
Hydrazones
|
PT100441A
(pt)
|
1991-05-02 |
1993-09-30 |
Smithkline Beecham Corp |
Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
|
US5451700A
(en)
|
1991-06-11 |
1995-09-19 |
Ciba-Geigy Corporation |
Amidino compounds, their manufacture and methods of treatment
|
NZ243082A
(en)
|
1991-06-28 |
1995-02-24 |
Ici Plc |
4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
|
AU661533B2
(en)
|
1992-01-20 |
1995-07-27 |
Astrazeneca Ab |
Quinazoline derivatives
|
NZ251092A
(en)
|
1992-04-02 |
1996-12-20 |
Smithkline Beecham Corp |
4-cyano-cyclohexane derivatives; medicaments; used in treating asthma
|
JP3192424B2
(ja)
|
1992-04-02 |
2001-07-30 |
スミスクライン・ビーチャム・コーポレイション |
アレルギーまたは炎症疾患の治療用化合物
|
MX9301942A
(es)
|
1992-04-02 |
1994-08-31 |
Smithkline Beecham Corp |
Derivados de ciclohexan-ilideno novedosos.
|
TW225528B
(pl)
|
1992-04-03 |
1994-06-21 |
Ciba Geigy Ag |
|
EP1167384B1
(en)
|
1992-10-28 |
2006-12-13 |
Genentech, Inc. |
HVEGF Receptor as Vascular endothelial cell growth factor antagonists
|
GB9301000D0
(en)
|
1993-01-20 |
1993-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
GB9314893D0
(en)
|
1993-07-19 |
1993-09-01 |
Zeneca Ltd |
Quinazoline derivatives
|
GB9414193D0
(en)
|
1994-07-14 |
1994-08-31 |
Glaxo Group Ltd |
Compounds
|
GB9414208D0
(en)
|
1994-07-14 |
1994-08-31 |
Glaxo Group Ltd |
Compounds
|
DE69536015D1
(de)
|
1995-03-30 |
2009-12-10 |
Pfizer Prod Inc |
Chinazolinone Derivate
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
US5843901A
(en)
|
1995-06-07 |
1998-12-01 |
Advanced Research & Technology Institute |
LHRH antagonist peptides
|
US5880141A
(en)
|
1995-06-07 |
1999-03-09 |
Sugen, Inc. |
Benzylidene-Z-indoline compounds for the treatment of disease
|
CA2224435C
(en)
|
1995-07-06 |
2008-08-05 |
Novartis Ag |
Pyrrolopyrimidines and processes for the preparation thereof
|
US5760041A
(en)
|
1996-02-05 |
1998-06-02 |
American Cyanamid Company |
4-aminoquinazoline EGFR Inhibitors
|
GB9603095D0
(en)
|
1996-02-14 |
1996-04-10 |
Zeneca Ltd |
Quinazoline derivatives
|
JP3370340B2
(ja)
|
1996-04-12 |
2003-01-27 |
ワーナー―ランバート・コンパニー |
チロシンキナーゼの不可逆的阻害剤
|
BR9709959A
(pt)
|
1996-06-24 |
2000-05-09 |
Pfizer |
Derivados tricìclicos de fenilamino substituìdo para o tratamento de doenças hiperproliferativas
|
WO1998008849A1
(de)
|
1996-08-30 |
1998-03-05 |
Novartis Aktiengesellschaft |
Verfahren zur herstellung von epothilonen und zwischenprodukte innerhalb des verfahrens
|
CA2264908C
(en)
|
1996-09-06 |
2006-04-25 |
Obducat Ab |
Method for anisotropic etching of structures in conducting materials
|
DE19638745C2
(de)
|
1996-09-11 |
2001-05-10 |
Schering Ag |
Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR)
|
CA2265630A1
(en)
|
1996-09-13 |
1998-03-19 |
Gerald Mcmahon |
Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
|
EP0837063A1
(en)
|
1996-10-17 |
1998-04-22 |
Pfizer Inc. |
4-Aminoquinazoline derivatives
|
GB9622386D0
(en)
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
DK1367057T3
(da)
|
1996-11-18 |
2009-01-19 |
Biotechnolog Forschung Gmbh |
Epothiloner E og F
|
US6441186B1
(en)
|
1996-12-13 |
2002-08-27 |
The Scripps Research Institute |
Epothilone analogs
|
TW528755B
(en)
|
1996-12-24 |
2003-04-21 |
Glaxo Group Ltd |
2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
|
CO4950519A1
(es)
|
1997-02-13 |
2000-09-01 |
Novartis Ag |
Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
|
CO4940418A1
(es)
|
1997-07-18 |
2000-07-24 |
Novartis Ag |
Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
|
US6166037A
(en)
|
1997-08-28 |
2000-12-26 |
Merck & Co., Inc. |
Pyrrolidine and piperidine modulators of chemokine receptor activity
|
AU9281298A
(en)
|
1997-10-01 |
1999-04-23 |
Kyowa Hakko Kogyo Co. Ltd. |
Benzodioxole derivatives
|
GB9721069D0
(en)
|
1997-10-03 |
1997-12-03 |
Pharmacia & Upjohn Spa |
Polymeric derivatives of camptothecin
|
GB9723566D0
(en)
|
1997-11-08 |
1998-01-07 |
Glaxo Group Ltd |
Chemical compounds
|
GB9723590D0
(en)
|
1997-11-08 |
1998-01-07 |
Glaxo Group Ltd |
Chemical compounds
|
GB9723589D0
(en)
|
1997-11-08 |
1998-01-07 |
Glaxo Group Ltd |
Chemical compounds
|
YU44900A
(sh)
|
1998-01-31 |
2003-01-31 |
Glaxo Group Limited |
Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
|
CO4990969A1
(es)
|
1998-02-14 |
2000-12-26 |
Glaxo Group Ltd |
Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol
|
US6194181B1
(en)
|
1998-02-19 |
2001-02-27 |
Novartis Ag |
Fermentative preparation process for and crystal forms of cytostatics
|
MXPA00008365A
(es)
|
1998-02-25 |
2002-11-07 |
Sloan Kettering Inst Cancer |
Sintesis de epotilonas, intermediarios y analogos de las mismas.
|
GB9813540D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
GB9813535D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
GB9813565D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
CN1313861A
(zh)
|
1998-06-23 |
2001-09-19 |
葛兰素集团有限公司 |
2-(嘌呤-9-基)-四氢呋喃-3,4-二醇衍生物
|
AU8180398A
(en)
|
1998-06-30 |
2000-01-17 |
Dow Global Technologies Inc. |
Polymer polyols and a process for the production thereof
|
DE69942097D1
(de)
|
1998-08-11 |
2010-04-15 |
Novartis Ag |
Isochinoline derivate mit angiogenesis-hemmender wirkung
|
WO2000023457A1
(en)
|
1998-10-16 |
2000-04-27 |
Pfizer Limited |
Adenine derivatives
|
UA71587C2
(uk)
|
1998-11-10 |
2004-12-15 |
Шерінг Акцієнгезелльшафт |
Аміди антранілової кислоти та їхнє застосування як лікарських засобів
|
GB9824579D0
(en)
|
1998-11-10 |
1999-01-06 |
Novartis Ag |
Organic compounds
|
NZ511722A
(en)
|
1998-11-20 |
2004-05-28 |
Kosan Biosciences Inc |
Recombinant methods and materials for producing epothilone and epothilone derivatives
|
IL143596A0
(en)
|
1998-12-22 |
2002-04-21 |
Genentech Inc |
Vascular endothelial cell growth factor antagonists and uses thereof
|
ATE329596T1
(de)
|
1999-03-30 |
2006-07-15 |
Novartis Pharma Gmbh |
Phthalazinderivate zur behandlung von entzündlicher erkrankungen
|
GB9913083D0
(en)
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
JP3894729B2
(ja)
|
1999-05-04 |
2007-03-22 |
シェーリング コーポレイション |
Ccr5アンタゴニストとして有用なピペラジン誘導体
|
WO2000066558A1
(en)
|
1999-05-04 |
2000-11-09 |
Schering Corporation |
Piperazine derivatives useful as ccr5 antagonists
|
YU25500A
(sh)
|
1999-05-11 |
2003-08-29 |
Pfizer Products Inc. |
Postupak za sintezu analoga nukleozida
|
GB9913932D0
(en)
|
1999-06-15 |
1999-08-18 |
Pfizer Ltd |
Purine derivatives
|
US6322771B1
(en)
|
1999-06-18 |
2001-11-27 |
University Of Virginia Patent Foundation |
Induction of pharmacological stress with adenosine receptor agonists
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
ES2260043T3
(es)
|
1999-08-21 |
2006-11-01 |
Altana Pharma Ag |
Combinacion sinergica de roflumilast y salmeterol.
|
CO5180581A1
(es)
|
1999-09-30 |
2002-07-30 |
Pfizer Prod Inc |
Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
|
GB9924361D0
(en)
|
1999-10-14 |
1999-12-15 |
Pfizer Ltd |
Purine derivatives
|
GB9924363D0
(en)
|
1999-10-14 |
1999-12-15 |
Pfizer Central Res |
Purine derivatives
|
GB0003960D0
(en)
|
2000-02-18 |
2000-04-12 |
Pfizer Ltd |
Purine derivatives
|
TWI227240B
(en)
|
2000-06-06 |
2005-02-01 |
Pfizer |
2-aminocarbonyl-9H-purine derivatives
|
ES2213703T5
(es)
|
2000-06-27 |
2011-11-02 |
Laboratorios S.A.L.V.A.T., S.A. |
Carbamatos derivados de arilalquilaminas.
|
GB0015727D0
(en)
|
2000-06-27 |
2000-08-16 |
Pfizer Ltd |
Purine derivatives
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
AR032471A1
(es)
|
2000-08-05 |
2003-11-12 |
Glaxo Group Ltd |
Derivado de androstano y solvatos del mismo, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden, procesos para preparar tales derivados, intermediarios utiles en la preparacion de tales derivados, procesos para preparar tales intermediarios, y compuestos inter
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
GB0022695D0
(en)
|
2000-09-15 |
2000-11-01 |
Pfizer Ltd |
Purine Derivatives
|
GB0028383D0
(en)
|
2000-11-21 |
2001-01-03 |
Novartis Ag |
Organic compounds
|
PL362989A1
(pl)
|
2000-12-22 |
2004-11-15 |
Almirall Prodesfarma Ag |
Nowe pochodne karbaminianu chinuklidyny i zawierające je kompozycje medyczne
|
JP4295985B2
(ja)
|
2000-12-28 |
2009-07-15 |
ラボラトリオス・アルミラル・ソシエダッド・アノニマ |
新規なキヌクリジン誘導体およびそれを含む医薬組成物
|
EP1241176A1
(en)
|
2001-03-16 |
2002-09-18 |
Pfizer Products Inc. |
Purine derivatives for the treatment of ischemia
|
PL366937A1
(pl)
|
2001-04-30 |
2005-02-07 |
Glaxo Group Limited |
Przeciwzapalne estrowe pochodne 17 beta-karbotianowe androstanu z cykliczną grupą estrową w pozycji17 alfa
|
AR035885A1
(es)
|
2001-05-14 |
2004-07-21 |
Novartis Ag |
Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica
|
WO2002096462A1
(en)
|
2001-05-25 |
2002-12-05 |
Pfizer Inc. |
An adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases
|
JP2005500290A
(ja)
|
2001-06-12 |
2005-01-06 |
グラクソ グループ リミテッド |
抗炎症性の、17β−カルボチオアートアンドロスタン誘導体である17α複素環エステル
|
DK2327765T3
(en)
|
2001-06-21 |
2015-07-13 |
Basf Enzymes Llc |
nitrilases
|
GB0119249D0
(en)
|
2001-08-07 |
2001-10-03 |
Novartis Ag |
Organic compounds
|
RU2004110717A
(ru)
|
2001-10-17 |
2005-10-20 |
Юсиби, С.А. (Be) |
Производные хинуклидина, способы их получения и их применение в качестве и нгибиторов м2- и/или м3- мускариновых рецепторов
|
GB0125259D0
(en)
|
2001-10-20 |
2001-12-12 |
Glaxo Group Ltd |
Novel compounds
|
AR037517A1
(es)
|
2001-11-05 |
2004-11-17 |
Novartis Ag |
Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
|
AU2002356759A1
(en)
|
2001-12-01 |
2003-06-17 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
EA006505B1
(ru)
|
2001-12-20 |
2005-12-29 |
Лабораториос С.А.Л.В.А.Т.,С.А. |
Производные карбамата 1-алкил-1-азониабицикло[2.2.2]октана и их применение в качестве антагонистов мускаринового рецептора
|
WO2003072592A1
(en)
|
2002-01-15 |
2003-09-04 |
Glaxo Group Limited |
17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
|
WO2003062259A2
(en)
|
2002-01-21 |
2003-07-31 |
Glaxo Group Limited |
Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
|
GB0202216D0
(en)
|
2002-01-31 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
CA2478156C
(en)
|
2002-03-26 |
2011-02-15 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
EP1490317A1
(en)
|
2002-03-26 |
2004-12-29 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
AU2003226211B2
(en)
*
|
2002-03-29 |
2008-05-29 |
Novartis Vaccines And Diagnostics, Inc. |
Substituted benzazoles and use thereof as RAF kinase inhibitors
|
AU2003234716A1
(en)
|
2002-04-10 |
2003-10-27 |
Joel M. Linden |
Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases
|
ES2206021B1
(es)
|
2002-04-16 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de pirrolidinio.
|
ES2201907B1
(es)
|
2002-05-29 |
2005-06-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
|
DE10224888A1
(de)
|
2002-06-05 |
2003-12-24 |
Merck Patent Gmbh |
Pyridazinderivate
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE10225574A1
(de)
|
2002-06-10 |
2003-12-18 |
Merck Patent Gmbh |
Aryloxime
|
DE10227269A1
(de)
|
2002-06-19 |
2004-01-08 |
Merck Patent Gmbh |
Thiazolderivate
|
ES2282667T3
(es)
|
2002-06-25 |
2007-10-16 |
Merck Frosst Canada Ltd. |
Inhibidores de pde4 8-(biaril)quinolinas.
|
ES2204295B1
(es)
|
2002-07-02 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de quinuclidina-amida.
|
WO2004005258A1
(en)
|
2002-07-02 |
2004-01-15 |
Merck Frosst Canada & Co. |
Di-aryl-substituted-ethane pyridone pde4 inhibitors
|
EP1521733B1
(en)
|
2002-07-08 |
2014-08-20 |
Pfizer Products Inc. |
Modulators of the glucocorticoid receptor
|
PE20050130A1
(es)
|
2002-08-09 |
2005-03-29 |
Novartis Ag |
Compuestos organicos
|
AU2003255376A1
(en)
|
2002-08-10 |
2004-03-11 |
Altana Pharma Ag |
Piperidine-derivatives as pde4 inhibitors
|
PL373146A1
(pl)
|
2002-08-10 |
2005-08-22 |
Altana Pharma Ag |
Pochodne pirydazynonu jako inhibitory PDE4
|
PL214701B1
(pl)
|
2002-08-10 |
2013-09-30 |
Nycomed Gmbh |
Pochodna piperydyny, kompozycja farmaceutyczna zawierajaca te pochodna oraz zastosowanie lecznicze tej pochodnej
|
AU2003260371A1
(en)
|
2002-08-10 |
2004-03-11 |
Altana Pharma Ag |
Piperidine-n-oxide-derivatives
|
WO2004018431A2
(en)
|
2002-08-17 |
2004-03-04 |
Altana Pharma Ag |
Novel phenanthridines
|
CA2495603A1
(en)
|
2002-08-17 |
2004-03-04 |
Altana Pharma Ag |
Benzonaphthyridines with pde 3/4 inhibiting activity
|
SE0202483D0
(sv)
|
2002-08-21 |
2002-08-21 |
Astrazeneca Ab |
Chemical compounds
|
US7288562B2
(en)
|
2002-08-23 |
2007-10-30 |
Ranbaxy Laboratories Limited |
Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists
|
WO2004019944A1
(en)
|
2002-08-29 |
2004-03-11 |
Altana Pharma Ag |
2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
|
WO2004019945A1
(en)
|
2002-08-29 |
2004-03-11 |
Altana Pharma Ag |
3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
|
PL376154A1
(pl)
|
2002-09-18 |
2005-12-27 |
Ono Pharmaceutical Co, Ltd. |
Pochodne triazaspiro[5.5]undekanu i leki zawierające te pochodne jako składnik aktywny
|
JP2006096662A
(ja)
|
2002-09-18 |
2006-04-13 |
Sumitomo Pharmaceut Co Ltd |
新規6−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
JP2004107299A
(ja)
|
2002-09-20 |
2004-04-08 |
Japan Energy Corp |
新規1−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
DE10246374A1
(de)
|
2002-10-04 |
2004-04-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
AU2003269317B2
(en)
|
2002-10-23 |
2009-10-29 |
Glenmark Pharmaceuticals Ltd. |
Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
DE10253426B4
(de)
|
2002-11-15 |
2005-09-22 |
Elbion Ag |
Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
|
DE10253282A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
|
DE10253220A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Dihydroxy-Methyl-Phenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
PE20130814A1
(es)
*
|
2006-08-30 |
2013-08-08 |
Novartis Ag |
Sales de benzimidazolil piridil eteres y formulaciones que las contienen
|